Assignee
GENESEN CO LTD
KR·3 granted patents·1 pending application·1 citations·filing 2015–2020
Top patents by PatentIndex Score
4 records- 0159US10435443B2Toll-like receptor 4 (TLR4) antagonistGENESEN CO LTD·Filed 2015·Granted Oct 8, 2019·1 cites·12 claims
- 0242US11661464B2Protein transduction domain, fusion compound containing the same, and pharmaceutical composition containing the fusion compoundGENESEN CO LTD·Filed 2020·Granted May 30, 2023·0 cites·9 claims
- 0336US11352399B2Peptide for toll-like receptor (TLR) inhibition and pharmaceutical composition comprising sameGENESEN CO LTD·Filed 2018·Granted Jun 7, 2022·0 cites·13 claims
- 0436US2022257782A1Peptide therapeutics for autoimmune diseases and inflammatory diseasesGENESEN CO LTD·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →